PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 30, 2026Journal of Clinical Oncology

Surgical management and survival in pelvic osteosarcoma.

View Full Paper
Ask AI
Bookmark
Share

Authors

SRSebastian RespicioMPMartin PhanCBChristopher Reese Bine

Discussion

Loading...

Member takes

Overview

Retrospective cohort analysis reveals surgical approaches impact survival in pelvic osteosarcoma, indicating tumor characteristics matter.

Key Points

  • Investigate survival outcomes associated with surgical management of pelvic osteosarcoma.
  • Conducted a retrospective cohort study using the National Cancer Database from 2004-2021.
  • Included patients diagnosed with pelvic osteosarcoma and performed statistical analyses including Chi-square and Cox regression.
  • Excluded patients with non-surgical management or incomplete survival data.
  • Pelvic amputation showed worse 5-year survival (92.3 months) compared to radical excision (124.5 months, p<0.001).
  • Positive surgical margins and NCDB Stage IV significantly predicted poorer survival (HR 8.415, p=0.002; HR 10.550, p=0.018).
  • Radiation therapy was linked to improved survival (HR 0.140, p=0.019).

Cite This Study

Respicio et al. (2026) studied this question.

synapsesocial.com/papers/6a1a81bf0307b78509433949https://doi.org/10.1200/jco.2026.44.16_suppl.e23502
View Full Paper
Ask AI
Bookmark
Share